Similar articles

• PegIFN/ribavirin during acute HCV coinfection.

  Bernard EJ. Bernard EJ. IAPAC Mon. 2004 Jul;10(7):260-1. IAPAC Mon. 2004. PMID: 15624247 No abstract available.
• Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

  Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, Katlama C. Dominguez S, et al. AIDS. 2006 May 12;20(8):1157-61. doi: 10.1097/01.aids.0000226956.02719.fd. AIDS. 2006. PMID: 16691067 Review.
• Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.

  Ramos B, Núñez M, Rendón A, Berdún MA, Losada E, Santos I, Echevarría S, Ocampo A, Miralles C, Arazo P, Barreiro P, Romero M, Labarga P, Guardiola JM, Garcia-Samaniego J, Soriano V. Ramos B, et al. J Viral Hepat. 2007 Jun;14(6):387-91. doi: 10.1111/j.1365-2893.2006.00806.x. J Viral Hepat. 2007. PMID: 17501758 Clinical Trial.
• Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.

  Martin-Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García-Samaniego J, López-Serrano P, Cordero M, Portu J, Soriano V. Martin-Carbonero L, et al. AIDS. 2008 Jan 2;22(1):15-21. doi: 10.1097/QAD.0b013e3282f1da99. AIDS. 2008. PMID: 18090387
• HIV and hepatitis C co-infection: acute HCV therapy.

  Boesecke C, Vogel M. Boesecke C, et al. Curr Opin HIV AIDS. 2011 Nov;6(6):459-64. doi: 10.1097/COH.0b013e32834b87de. Curr Opin HIV AIDS. 2011. PMID: 22001891 Review.